TrialClinical drug investigation2015

Cost effectiveness of mirabegron compared with tolterodine extended release for the treatment of adults with overactive bladder in the United Kingdom.

Samuel Aballéa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.